These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27759462)

  • 1. Peripheral and Intestinal T-regulatory Cells are Upregulated in Children with Inflammatory Bowel Disease at Onset of Disease.
    Sznurkowska K; Żawrocki A; Sznurkowski J; Zieliński M; Landowski P; Plata-Nazar K; Iżycka-Świeszewska E; Trzonkowski P; Szlagatys-Sidorkiewicz A; Kamińska B
    Immunol Invest; 2016 Nov; 45(8):787-796. PubMed ID: 27759462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of Circulating and Intestinal T Regulatory Cells and Their Expression of Helios and Neuropilin-1 in Children with Inflammatory Bowel Disease.
    Sznurkowska K; Luty J; Bryl E; Witkowski JM; Hermann-Okoniewska B; Landowski P; Kosek M; Szlagatys-Sidorkiewicz A
    J Inflamm Res; 2020; 13():995-1005. PubMed ID: 33273840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients.
    Reikvam DH; Perminow G; Lyckander LG; Gran JM; Brandtzaeg P; Vatn M; Carlsen HS
    Scand J Gastroenterol; 2011 May; 46(5):550-60. PubMed ID: 21281255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.
    Maul J; Loddenkemper C; Mundt P; Berg E; Giese T; Stallmach A; Zeitz M; Duchmann R
    Gastroenterology; 2005 Jun; 128(7):1868-78. PubMed ID: 15940622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
    Li Z; Arijs I; De Hertogh G; Vermeire S; Noman M; Bullens D; Coorevits L; Sagaert X; Schuit F; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1299-310. PubMed ID: 20196149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
    Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
    J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel disease.
    Ban H; Andoh A; Shioya M; Nishida A; Tsujikawa T; Fujiyama Y
    Mol Med Rep; 2008; 1(5):647-50. PubMed ID: 21479463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.
    Tiwari V; Kedia S; Garg SK; Rampal R; Mouli VP; Purwar A; Mitra DK; Das P; Dattagupta S; Makharia G; Acharya SK; Ahuja V
    PLoS One; 2018; 13(2):e0193433. PubMed ID: 29489879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.
    Kelsen J; Agnholt J; Hoffmann HJ; Rømer JL; Hvas CL; Dahlerup JF
    Clin Exp Immunol; 2005 Sep; 141(3):549-57. PubMed ID: 16045746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
    Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
    Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease.
    Wang Y; Liu XP; Zhao ZB; Chen JH; Yu CG
    J Dig Dis; 2011 Aug; 12(4):286-94. PubMed ID: 21791023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.
    Cuadrado E; Alonso M; de Juan MD; Echaniz P; Arenas JI
    World J Gastroenterol; 2008 Mar; 14(10):1521-7. PubMed ID: 18330941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3- Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy.
    Li Z; Vermeire S; Bullens D; Ferrante M; Van Steen K; Noman M; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2418-28. PubMed ID: 26308438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood regulatory T cells in inflammatory bowel disease, a systematic review, and meta-analysis.
    Jalalvand M; Enayati S; Akhtari M; Madreseh E; Jamshidi A; Farhadi E; Mahmoudi M; Amirzargar A
    Int Immunopharmacol; 2023 Apr; 117():109824. PubMed ID: 36827916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.